BlackRock’s Dimension Therapeutics, Inc DMTX Stock Holding History
Bought
Maintained
Sold
BlackRock's DMTX Position: Q4 2017 in Review
BlackRock sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 32,570 shares — an estimated $196K sold.
BlackRock first reported a position in DMTX in Q1 2016 and held it in 7 quarters. The position peaked at $969K in Q1 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.
- BlackRock reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
- BlackRock sold 32,570 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $196K.
- BlackRock first reported a position in Dimension Therapeutics, Inc in Q1 2016 and held it in 7 quarters.
- BlackRock's Dimension Therapeutics, Inc position peaked at $969K in Q1 2017.
- 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.